INVO Fertility, Inc.
IVF Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 23, 2026
$0.57
KIRA · Stoqly’s AI analyst, in plain words
- INVO Fertility, Inc. had $6.8M of revenue in fiscal 2025, up 4.7% on the year before. Over five years, revenue changed +45.8% a year on average.
- Its operating margin was −105.8%, down 4.3 pts: of every 100 in sales, about −106 is left after running the business.
- INVO Fertility, Inc. lost $23.3M in fiscal 2025.
- Free cash flow was −$7.1M in fiscal 2025, −103.2% of revenue.
- INVO Fertility, Inc. has $1.2M more cash than debt.
Market cap
$1.5M
P/E
0.0x
Revenue
$6.8M
Net income
−$23.3M
Free cash flow
−$7.1M
Operating margin
−105.8%
INVO Fertility, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+4.7%
Only a little. Sales grew 4.7% last year.
Does it make a profit?
−340.9%
No. It lost money last year.
Does profit turn into cash?
−103.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
0.0x
One share costs 0.0 times its yearly profit per share.
What INVO Fertility, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Jun 2, 2026
- Legal name
- INVO Fertility, Inc.
- CIK
- 0001417926
INVO Fertility, Inc. · IVF
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $4.2M | $0.8M | $3.0M | $6.5M | $6.8M |
| Revenue growth | 301.1% | −80.2% | 267.4% | 116.2% | 4.7% |
| Gross margin | 96.5% | 59.7% | 34.7% | 43.1% | 99.6% |
| Operating margin | −125.4% | −1,292.4% | −224.0% | −101.5% | −105.8% |
| Net income | −$6.7M | −$10.9M | −$8.0M | −$9.3M | −$23.3M |
| Net margin | −160.0% | −1,324.8% | −266.0% | −141.7% | −340.9% |
| Diluted EPS | −$0.63 | −$17.97 | −$67.37 | −$3,782.65 | −$214.64 |
| Cash | |||||
| Cash from operations | −$6.0M | −$6.6M | −$4.8M | −$3.0M | −$7.0M |
| Capital expenditure | $0.4M | $0.0M | $0.4M | $0.2M | $0.0M |
| Free cash flow | −$6.4M | −$6.6M | −$5.2M | −$3.2M | −$7.1M |
| FCF margin | −154.9% | −804.4% | −172.1% | −48.3% | −103.2% |
| Share count change | 93.7% | −94.3% | −80.3% | −97.9% | 4,584.0% |
| Debt and strength | |||||
| Cash and short-term investments | $5.7M | $0.1M | $0.2M | $0.6M | $2.1M |
| Debt incl. finance leases | — | — | — | $7.5M | $0.9M |
| Shareholders' equity | $7.3M | −$1.0M | $0.9M | $12.6M | $7.2M |
| Current ratio | 5.4x | 0.2x | 0.2x | 0.1x | 0.3x |
| Interest coverage | −4.1x | −178.9x | −7.3x | −6.3x | −5.6x |
| Returns and quality | |||||
| Return on capital | — | — | — | −26.9% | −94.7% |
| Return on equity | −102.0% | −344.0% | — | −137.4% | −235.5% |
| Return on tangible equity | −92.7% | — | — | −277.3% | −125,025.9% |
| Piotroski F-score | 5 | 2 | 3 | 4 | 5 |
| Altman Z'' | −10.0 | −68.0 | −15.0 | −7.6 | −19.0 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
1 insider
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
INVO Fertility, Inc. · IVF
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.57 a share, the company is worth $1.5M: 0.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001417926). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.